Preclinical assessment of the selective androgen receptor modulator RAD140 to increase muscle mass and bone mineral density

Selective androgen receptor modulators (SARMs) are important hypertrophic molecules that are potential treatments for many types of myopathy and osteopathy. This study aimed to determine if the SARM RAD140 had additive effects on muscle hypertrophy when combined with the functional overloading (FO) of the plantaris muscle. Male, Sprague-Dawley rats (n = 10 rats/group) were randomly selected into one of four treatment groups: (1) RAD140-FO, (2) RAD140-Control, (3) Vehicle-Control, or (4) Vehicle-FO. RAD140 groups received drugs through drinking water, and control groups received only Vehicle (methylcellulose). Standard rat chow and water were provided ad libitum. Muscle weights of the triceps-surae group and muscle fiber cross-sectional area (CSA) were measured. Muscle weight analysis showed a marked increase in RAD140-FO groups but was not statistically different from the Vehicle-FO group. CSA results indicated similar findings; however, RAD140-Control showed significantly elevated CSA compared to Vehicle-Control. The tibial microarchitecture was analyzed using micro computed tomography. RAD140 did not impact cortical or trabecular bone structural morphometric properties following 14 days of treatment. The data presented here show the potential of RAD140 to stimulate muscle hypertrophy in young healthy rats.